Evidence map›Paper›PMID 36648562›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2023

Early-onset motor polyneuropathy associated with a novel dominant NAGLU mutation.

Diego Lopergolo, Simona Salvatore, Vincenzo Sorrentino, Alessandro Malandrini, Filippo Maria Santorelli, Carla Battisti

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Diego LopergoloDepartment of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy. diego.lopergolo@unifi.it.ORCID http://orcid.org/0000-0003-2256-0482
Simona SalvatoreDepartment of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
Vincenzo SorrentinoDepartment of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
Alessandro MalandriniDepartment of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
Filippo Maria SantorelliMolecular Medicine and Neurogenetics, IRCCS Fondazione Stella Maris, Pisa, Italy.
Carla BattistiDepartment of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
University of Siena · ITFondazione Stella Maris · IT

Funding

Fondazione Telethon GGP19291Regione Toscana 26-09-2018Regione Toscana "Bando Ricerca Salute 2018"Regione Toscana Decree n. 15397
6 · The paper itself

Abstract

introductionNAGLU encodes N-acetyl-alpha-glucosaminidase, an enzyme that degrades heparan sulfate. Biallelic NAGLU mutations cause mucopolysaccharidosis IIIB, a severe childhood-onset neurodegenerative disease, while monoallelic mutations are associated to late-onset, dominantly inherited painful sensory neuropathy. However, to date, only one family with a dominant NAGLU-related neuropathy has been described. CASE REPORT: Here we describe a patient with early-onset motor polyneuropathy harboring a novel monoallelic NAGLU mutation. We found reduced NAGLU enzymatic activity thus corroborating the pathogenic role of the new variant. DISCUSSION: Our report represents the second ever described case with dominant NAGLU-related neuropathy and the first case with early-onset motor symptoms. We underlie the importance of a thorough clinical description of this probably underestimated new clinical entity.

Indexed as

Hereditary Sensory and Autonomic NeuropathiesMucopolysaccharidosis IIINeurodegenerative DiseasesPeripheral Nervous System DiseasesPolyneuropathiesAcetylglucosaminidaseChildHumansMutationAcetylglucosaminidasealpha-N-acetyl-D-glucosaminidaseNAGLUNeuropathy

Identifiers

PMID36648562
OpenAlexW4316927957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.